LPL Financial’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
LPL Financial's SGMT Position: Q3 2026 in Review
LPL Financial reduced its Sagimet Biosciences (SGMT) stake by 18% in Q3 2026, selling an estimated $44.4K and leaving 21,920 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #5764.
LPL Financial first reported a position in SGMT in Q1 2024 and has held it in 6 quarters since. The position peaked at $222K in Q1 2024. 153 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.
- LPL Financial held 21,920 shares of Sagimet Biosciences worth $217K as of Q3 2026.
- LPL Financial sold 4,830 Sagimet Biosciences shares in Q3 2026, an estimated $44.4K.
- Sagimet Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #5764 holding.
- LPL Financial first reported a position in Sagimet Biosciences in Q1 2024 and has held it in 6 quarters since.
- LPL Financial's Sagimet Biosciences position peaked at $222K in Q1 2024.
- 153 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.